Study of AZD5305 as monotherapy and in combination with anti-cancer agents in patients with advanced solid malignancies

Trial Identifier: D9720C00001
Sponsor: AstraZeneca
Start Date: November 2020
Primary Completion Date: March 2027
Study Completion Date: March 2027
Condition: Bladder Cancer; Breast Cancer; Cancer - Other; Colorectal Cancer; Endometrial Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations